CLINICAL FEATURES OF TYPE 2 DIABETES DIFFERENT PHENOTYPES

QR Code

CLINICAL FEATURES OF TYPE 2 DIABETES DIFFERENT PHENOTYPES

Objective of the study was to investigate clinical features of phenotypic variants of type 2 diabetes mellitus (T2DM) for personalization of hypoglycemic therapy. Material and methods. 2085 patients with T2DM (637 men and 1148 women), mean age 58.7 ± 6.9 years, duration of diabetes 7.8 ± 6.5 years;...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. Yu. Shabelnikova, I. A. Bondar
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Siberian Branch Publishing House 2020-03-01
Series:	Сибирский научный медицинский журнал
Subjects:	type 2 diabetes mellitus phenotype insulin resistance personalized therapy chronic kidney disease
Online Access:	https://sibmed.elpub.ru/jour/article/view/343
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

IRISIN, OBESITY AND TYPE II DIABETES MELLITUS
by: Zainab Fathi, et al.
Published: (2025-03-01)

Contributions of Hepatic Insulin Resistance and Islet β-Cell Dysfunction to the Blood Glucose Spectrum in Newly Diagnosed Type 2 Diabetes Mellitus
by: Mengge Yang, et al.
Published: (2025-07-01)

Recombinant Irisin Ameliorates Insulin Resistance in Type 2 Diabetic Mice
by: Sana Akram, et al.
Published: (2025-03-01)

GLYCEMIA CONTROL, INSULIN RESISTANCE, AND FUNCTIONAL ACTIVITY OF T-HELPER SUBPOPULATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
by: I. V. Kologrivova, et al.
Published: (2014-03-01)

Mice experimental model of diabetes mellitus type ii based on high fat diet
by: L. V. Kapilevich, et al.
Published: (2019-10-01)

The Interplay Between Obesity and Type 2 Diabetes: Common Pathophysiological Mechanisms Contributing to Telomere Shortening
by: Stella Baliou, et al.
Published: (2025-05-01)

Recent advances in the treatment of type 2 diabetes mellitus with obesity
by: S. V. Yargin
Published: (2021-06-01)

Type 1 diabetes mellitus in chronic insulin deﬁciency conditions
by: A. Yu. Surovtseva, et al.
Published: (2021-07-01)

Clinical characteristics of patients with gestational diabetes mellitus depending on the type of treatment (a retrospective study)
by: N. I. Volkova, et al.
Published: (2024-12-01)

The relationship between melatonin levels and insulin resistance in patients with type 2 diabetes mellitus under chronic war stress
by: M.I. Bobryk, et al.
Published: (2025-04-01)

Functional and Therapeutic Roles of Plant-Derived Antioxidants in Type 2 Diabetes Mellitus: Mechanisms, Challenges, and Considerations for Special Populations
by: Vicente Javier Clemente-Suárez, et al.
Published: (2025-06-01)

Gender-associated features in diabetic kidney disease
by: S.S. Safarova
Published: (2024-10-01)

Relationship of chronic kidney disease of the with glycemic status, cardiovascular diseases and laboratory indicators in patients with type 2 diabetes mellitus
by: S. Kh. Mehdiyev, et al.
Published: (2019-06-01)

PROGRESSING CHRONIC KIDNEY DISEASE AND THE 12-MONTH DYNAMICS OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS
by: A. V. Markova, et al.
Published: (2013-10-01)

Endothelium protecting properties of taurin in chronic heart failure with type 2 diabetes
by: M. E. Stacenko, et al.
Published: (2016-04-01)

MEXICOR IN THE COMBINATION THERAPY OF CHRONIC HEART FAILURE AND TYPE 2 DIABETES MELLITUS
by: M. E. Statsenko, et al.
Published: (2011-12-01)

A review of type 2 diabetes mellitus and cognitive impairment
by: Wen Kan, et al.
Published: (2025-08-01)

Frequency of detection and factors of elevated levels of diabetes-associated autoantibodies in the blood of patients with clinical type 2 diabetes mellitus
by: Y.A. Saienko, et al.
Published: (2025-04-01)

Early outcomes of kidney transplantation in recipients with type 1 diabetes mellitus and end‑stage kidney disease resulting from diabetic nephropathy
by: K. E. Lazareva, et al.
Published: (2025-01-01)

Early start of insulin therapy in type 2 diabetes mellitus: pros and cons
by: S. V. Yargin
Published: (2021-07-01)

Clinical features of the course of overt diabetes mellitus during pregnancy
by: A. V. Tiselko, et al.
Published: (2022-03-01)

Associations of Leukocyte-Derived Chemotaxin-2 (LECT2) with Insulin Resistance and Metabolic Syndrome in Type 2 Diabetes: A Cross-Sectional Study
by: Sha Y, et al.
Published: (2025-07-01)

Advancement of artificial intelligence based treatment strategy in type 2 diabetes: A critical update
by: Aniruddha Sen, et al.
Published: (2025-06-01)

Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis
by: E. V. Biryukova, et al.
Published: (2017-11-01)

Gestational diabetes and parental type 2 diabetes as risk indicators for type 1 diabetes in offspring: a systematic review and meta-analysisResearch in context
by: Isabella Albanese, et al.
Published: (2025-07-01)

Predictors of adherence to insulin therapy in type 2 diabetes mellitus: an application of the theory of planned behavior
by: Mariane Karin de Moraes Oliveira, et al.
Published: (2025-12-01)

Data-driven cluster analysis on the association of aging, obesity and insulin resistance with new-onset diabetes in Chinese adults: a multicenter retrospective cohort study
by: Yazhi Wang, et al.
Published: (2025-07-01)

TYPE 2 DIABETES MELLITUS’S DECOMPENSATED FORM: ON THE PROBLEM OF EFFECTIVE PHARMACOTHERAPY IN REAL CLINICAL PRACTICE
by: A. V. Safronenko, et al.
Published: (2021-10-01)

Difficulties of stable metabolic compensation of type 1 diabetes mellitus in adolescents
by: E. B. Bashnina, et al.
Published: (2021-06-01)

Possibilities of using different indices of insulin resistance in various subtypes of gestational diabetes mellitus
by: I. Yu. Davidenko, et al.
Published: (2024-06-01)

Knowledge, Attitude, And Practice in Diabetic Kidney Disease Prevention and Its Associated Factor Among Type 2 Diabetes Mellitus Patients in Northeast Peninsular Malaysia
by: Anas Bin Rosedi, et al.
Published: (2025-07-01)

A RESISTANCE TO LEPTIN IN DEVELOPMENT OF DIFFERENT OBESITY PHENOTYPES
by: A. V. Ott, et al.
Published: (2016-04-01)

Combination of a high-carbohydrate diet and streptozotoc in for modeling type 2 diabetes in Wistar rats
by: S. V. Ivanov, et al.
Published: (2023-07-01)

EXPERIENCE WITH THE ROSINSULIN C IN COMBINATION WITH ORAL ANTIDIABETIC DRUGS IN PATIENTS WITH TYPE 2 DIABETES IN ROUTINE CLINICAL PRACTICE
by: O. D. Rymar, et al.
Published: (2014-04-01)

Anti-Diabetic and Antioxidant Effect Evaluation of Thai Shallot and Cha-Miang in Diabetic Rats
by: Jiraporn Laoung-on, et al.
Published: (2025-05-01)

The Effects of Adipose Tissue Dysregulation on Type 2 Diabetes Mellitus
by: Jamie Rausch, et al.
Published: (2025-07-01)

Effectiveness and Safety of DLBS3233 in Newly Diagnosed Type 2 Diabetes Mellitus: A 12-week Clinical Trial
by: Heri Nugroho, et al.
Published: (2024-10-01)

Overview of tea constituents against type 2 diabetes
by: LU Peng, et al.
Published: (2016-05-01)

CLINICAL AND BIOCHEMICAL PREDICTORS OF DIABETES MELLITUS MANIFESTATION AFTER MYOCARDIAL INFARCTION
by: O. L. Barbarash, et al.
Published: (2014-03-01)

Early markers of renal damage in type 2 diabetes: role of vitamin D-binding protein
by: V.M. Yerokhovych, et al.
Published: (2025-04-01)